Filed: 11/14/2022ACC: 0001387131-22-011394
📋 What this filing means
AFFINITY ASSET ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 56 equity positions with a total reported market value of $358.3K. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
56
Positions
$358.3K
Total AUM (reported)
55.47M
Total Shares
Allocation by class
COM$146.4K40.9%
TR UNIT$89.3K24.9%
SPONSORED ADR$55.7K15.5%
COM NEW$12.5K3.5%
RUSSELL 2000 ETF$11.5K3.2%
NOTE 2.500% 9/1$11.1K3.1%
NOTE 2.625% 3/0$8.5K2.4%
Portfolio Concentration
Top 3$128.0K35.7%
4–10$88.0K24.5%
11–25$92.2K25.7%
Rest$50.1K14.0%
Top 3 weight
35.7%
Top 10 weight
60.3%
Voting Authority Distribution
Total shares with voting rights: 55.47M
Sole
Full voting authority
55.47M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole56
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings56
Rows:
SPDR S&P 500 ETF TR
SOLEShares250K
TypeSH
Market value$89.3K
24.92%
Sole
250K
Shared
0.00
None
0.00
SANOFI
SOLEShares550K
TypeSH
Market value$20.9K
5.84%
Sole
550K
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares326.67K
TypeSH
Market value$17.8K
4.98%
Sole
326.67K
Shared
0.00
None
0.00
CHINOOK THERAPEUTICS INC
SOLEShares814K
TypeSH
Market value$16.0K
4.47%
Sole
814K
Shared
0.00
None
0.00
ASTRAZENECA PLC
SOLEShares250K
TypeSH
Market value$13.7K
3.83%
Sole
250K
Shared
0.00
None
0.00
GLOBAL BLOOD THERAPEUTICS IN
SOLEShares190K
TypeSH
Market value$12.9K
3.61%
Sole
190K
Shared
0.00
None
0.00
ISHARES TR
SOLEShares70K
TypeSH
Market value$11.5K
3.22%
Sole
70K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares175K
TypeSH
Market value$11.4K
3.17%
Sole
175K
Shared
0.00
None
0.00
LANTHEUS HLDGS INC
SOLEShares160K
TypeSH
Market value$11.3K
3.14%
Sole
160K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares11M
TypePRN
Market value$11.1K
3.11%
Sole
11M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares100K
TypeSH
Market value$10.3K
2.88%
Sole
100K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares712.85K
TypeSH
Market value$9.7K
2.72%
Sole
712.85K
Shared
0.00
None
0.00
INARI MED INC
SOLEShares120K
TypeSH
Market value$8.7K
2.43%
Sole
120K
Shared
0.00
None
0.00
NANOSTRING TECHNOLOGIES INC
SOLEShares10M
TypePRN
Market value$8.5K
2.38%
Sole
10M
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares170K
TypeSH
Market value$5.9K
1.66%
Sole
170K
Shared
0.00
None
0.00
POINT BIOPHARMA GLOBAL INC
SOLEShares746.58K
TypeSH
Market value$5.8K
1.61%
Sole
746.58K
Shared
0.00
None
0.00
GSK PLC
SOLEShares185K
TypeSH
Market value$5.4K
1.52%
Sole
185K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares515.10K
TypeSH
Market value$5.3K
1.47%
Sole
515.10K
Shared
0.00
None
0.00
BELLUS HEALTH INC NEW
SOLEShares473.60K
TypeSH
Market value$5.0K
1.40%
Sole
473.60K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares175K
TypeSH
Market value$5.0K
1.39%
Sole
175K
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares25K
TypeSH
Market value$4.7K
1.32%
Sole
25K
Shared
0.00
None
0.00
CYMABAY THERAPEUTICS INC
SOLEShares1.29M
TypeSH
Market value$4.5K
1.26%
Sole
1.29M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares7.50M
TypePRN
Market value$4.5K
1.25%
Sole
7.50M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares10M
TypePRN
Market value$4.4K
1.24%
Sole
10M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares267.79K
TypeSH
Market value$4.3K
1.19%
Sole
267.79K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P 500 ETF TRSOLE | TR UNIT | 250K | SH | $89.3K 24.92% | 250K | 0.00 | 0.00 |
SANOFISOLE | SPONSORED ADR | 550K | SH | $20.9K 5.84% | 550K | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 326.67K | SH | $17.8K 4.98% | 326.67K | 0.00 | 0.00 |
CHINOOK THERAPEUTICS INCSOLE | COM | 814K | SH | $16.0K 4.47% | 814K | 0.00 | 0.00 |
ASTRAZENECA PLCSOLE | SPONSORED ADR | 250K | SH | $13.7K 3.83% | 250K | 0.00 | 0.00 |
GLOBAL BLOOD THERAPEUTICS INSOLE | COM | 190K | SH | $12.9K 3.61% | 190K | 0.00 | 0.00 |
ISHARES TRSOLE | RUSSELL 2000 ETF | 70K | SH | $11.5K 3.22% | 70K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 175K | SH | $11.4K 3.17% | 175K | 0.00 | 0.00 |
LANTHEUS HLDGS INCSOLE | COM | 160K | SH | $11.3K 3.14% | 160K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 11M | PRN | $11.1K 3.11% | 11M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 100K | SH | $10.3K 2.88% | 100K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 712.85K | SH | $9.7K 2.72% | 712.85K | 0.00 | 0.00 |
INARI MED INCSOLE | COM | 120K | SH | $8.7K 2.43% | 120K | 0.00 | 0.00 |
NANOSTRING TECHNOLOGIES INCSOLE | NOTE 2.625% 3/0 | 10M | PRN | $8.5K 2.38% | 10M | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 170K | SH | $5.9K 1.66% | 170K | 0.00 | 0.00 |
POINT BIOPHARMA GLOBAL INCSOLE | COM | 746.58K | SH | $5.8K 1.61% | 746.58K | 0.00 | 0.00 |
GSK PLCSOLE | SPONSORED ADR | 185K | SH | $5.4K 1.52% | 185K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADR | 515.10K | SH | $5.3K 1.47% | 515.10K | 0.00 | 0.00 |
BELLUS HEALTH INC NEWSOLE | COM NEW | 473.60K | SH | $5.0K 1.40% | 473.60K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 175K | SH | $5.0K 1.39% | 175K | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 25K | SH | $4.7K 1.32% | 25K | 0.00 | 0.00 |
CYMABAY THERAPEUTICS INCSOLE | COM | 1.29M | SH | $4.5K 1.26% | 1.29M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 7.50M | PRN | $4.5K 1.25% | 7.50M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.250% 2/0 | 10M | PRN | $4.4K 1.24% | 10M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 267.79K | SH | $4.3K 1.19% | 267.79K | 0.00 | 0.00 |
Page 1 of 3